HLA Screening in Reducing the Risk of Antiepileptic Drug-induced Cutaneous Adverse Reactions
Clinical trial NCT03184597 · UNKNOWN
Trial details
- NCT number
- NCT03184597
- Sponsor
- Second Affiliated Hospital of Guangzhou Medical University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-01
- Primary completion
- 2021-06-01
- Enrollment
- 4000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.